Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 4
2005 6
2006 5
2007 10
2008 7
2009 8
2010 6
2011 4
2012 7
2013 6
2014 8
2015 8
2016 8
2017 7
2018 7
2019 8
2020 4
2021 5
2022 2
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
ABCG2 as a therapeutic target candidate for gout.
Fujita K, Ichida K. Fujita K, et al. Expert Opin Ther Targets. 2018 Feb;22(2):123-129. doi: 10.1080/14728222.2018.1420167. Epub 2017 Dec 28. Expert Opin Ther Targets. 2018. PMID: 29264928 Review.
Choline dihydrogen phosphate.
Fujita K, Macfarlane DR, Noguchi K, Ohno H. Fujita K, et al. Acta Crystallogr Sect E Struct Rep Online. 2009 Mar 6;65(Pt 4):o709. doi: 10.1107/S1600536809007259. Acta Crystallogr Sect E Struct Rep Online. 2009. PMID: 21582446 Free PMC article.
Clinical time course of pediatric acute disseminated encephalomyelitis.
Nishiyama M, Nagase H, Tomioka K, Tanaka T, Yamaguchi H, Ishida Y, Toyoshima D, Fujita K, Maruyama A, Sasaki K, Oyazato Y, Nakagawa T, Takami Y, Nozu K, Nishimura N, Nakashima I, Iijima K. Nishiyama M, et al. Among authors: fujita k. Brain Dev. 2019 Jun;41(6):531-537. doi: 10.1016/j.braindev.2019.02.011. Epub 2019 Mar 2. Brain Dev. 2019. PMID: 30833092
Corrigendum to: "Detailed clinical course of fatal acute encephalopathy in children" [Brain Dev. 41(8) (2019) 691-698].
Tomioka K, Nishiyama M, Nagase H, Ishida Y, Tanaka T, Tokumoto S, Yamaguchi H, Toyoshima D, Maruyama A, Fujita K, Aoki K, Seino Y, Nozu K, Nishimura N, Kurosawa H, Iijima K. Tomioka K, et al. Among authors: fujita k. Brain Dev. 2022 Nov;44(10):771-772. doi: 10.1016/j.braindev.2022.07.006. Epub 2022 Aug 30. Brain Dev. 2022. PMID: 36055910 No abstract available.
[A whole genome cloning in the BGM vector].
Itaya M, Tsuge K, Koizumi M, Fujita K. Itaya M, et al. Among authors: fujita k. Tanpakushitsu Kakusan Koso. 2006 Jan;51(1):61-7. Tanpakushitsu Kakusan Koso. 2006. PMID: 16416884 Review. Japanese. No abstract available.
Clinical features in very early-onset demyelinating disease with anti-MOG antibody.
Nishiyama M, Nagase H, Matsumoto M, Tomioka K, Awano H, Tanaka T, Toyoshima D, Fujita K, Maruyama A, Oyazato Y, Saeki K, Shiraishi K, Takada S, Kaneko K, Takahashi T, Nakashima I, Iijima K. Nishiyama M, et al. Among authors: fujita k. Brain Dev. 2017 Oct;39(9):756-762. doi: 10.1016/j.braindev.2017.05.004. Epub 2017 May 24. Brain Dev. 2017. PMID: 28551039
Detailed clinical course of fatal acute encephalopathy in children.
Tomioka K, Nishiyama M, Nagase H, Ishida Y, Tanaka T, Tokumoto S, Yamaguchi H, Toyoshima D, Maruyama A, Fujita K, Aoki K, Seino Y, Nozu K, Nishimura N, Kurosawa H, Iijima K. Tomioka K, et al. Among authors: fujita k. Brain Dev. 2019 Sep;41(8):691-698. doi: 10.1016/j.braindev.2019.04.012. Epub 2019 Jul 20. Brain Dev. 2019. PMID: 31337523
116 results